Navigation Links
MBL director and CEO and cell biology pioneer Gary Borisy elected to National Academy of Sciences
Date:4/28/2009

Research UK. "The identification of tubulin was a landmark, a turning point in the field."

In 2006 Dr. Borisy became the MBL's 13th Director and 3rd CEO. Previously he was Associate Vice President for Research and the Leslie B. Arey Professor of Cell and Molecular Biology at Northwestern University's Feinberg School of Medicine. He received his B.S. and Ph.D. from the University of Chicago. After serving a postdoctoral fellowship at the MRC in Cambridge, England, Dr. Borisy joined the faculty of the University of Wisconsin, Madison, rising through the professional ranks to Chairman of the Laboratory of Molecular Biology and Perlman-Bascom Professor of Life Sciences, before moving to Northwestern in 2000.

Dr. Borisy first came to the MBL in 1965 as a student and returned in 1972 to establish a summer laboratory where he conducted research for five years on cytoskeleton formation. He also served as a consultant to the MBL's Physiology course in 1982 and 1983.

As director and CEO, Dr. Borisy has played a key role in numerous MBL accomplishments, including the acquisition of $10 million in state funds awarded to the MBL last year as part of the historic $1 billion Massachusetts Life Sciences Act. Most recently, Dr. Borisy was instrumental in the formation of the Woods Hole Consortium, a new alliance between the MBL, the Woods Hole Oceanographic Institution, and the Woods Hole Research Center that brings the combined scientific power of the three institutions to bear on some of the major issues facing society today.

In addition to his administrative duties, Dr. Borisy also leads the MBL's Combinatorial Imaging Group, which is developing new imaging techniques to observe and identify different species of microbes, such as bacteria.

Dr. Borisy is the author of more than 200 papers, the editor of two books, and has received numerous professional honors, including an NIH Merit award and the Carl Zeiss award from the German So
'/>"/>

Contact: Gina Hebert
ghebert@mbl.edu
508-289-7725
Marine Biological Laboratory
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Fujitsu PalmSecure LOGONDIRECTOR Integrates with Passlogix v-GO Access Accelerator Suite
2. Fujitsu PalmSecure LOGONDIRECTOR Integrates with Passlogix v-GO Access Accelerator Suite
3. Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial
4. Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready
5. bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors
6. Julia Zeitlinger selected for NIH Directors New Innovator Award
7. Fujitsu Announces PalmSecure(TM) LOGONDIRECTOR
8. Solidus Networks, Inc. Seats New Board of Directors
9. Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States
10. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
11. Director of National Intelligence to Speak at Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...  23andMe, Inc., the leading personal genetics company, today announced the ... ancestry of individuals from across the United States ... four hundred years ago, the United States ... different continents. This study illuminates how American history and the ...
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced today its ... confirm its adherence to current U.S. Food and Drug ... regulated smart device and smart phone application trials utilizing ... "HITLAB is determined to improve global healthcare ...
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a technology ... measures the overall facial feature of a person such ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... Infectious Diseases (NIAID), part of the National Institutes ... $80 million for two new Regional Centers of ... (RCE). The grants to the University of California, ... the completion of a national network of academic ...
... with implications for pandemic influenza, a new study reports for ... virus can spread from poultry to humans. The research ... Infectious Diseases, now available online. , Crossing the species barrier ... virus with pandemic potential. Previous studies have focused on the ...
... problem of "super-bugs" - bacteria that have become resistant ... high rate of antibiotic prescribing in hospitals contributes to ... antibiotics, an even more important factor contributing to such ... access international medical journal PLoS Medicine, is the use ...
Cached Biology News:New NIAID grants strengthen national biodefense and emerging infectious diseases research network 2Less virulent strains of avian influenza can infect humans 2Agricultural antibiotic use contributes to 'super-bugs' in humans 2
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 ... technologies such as the Bioruptor® and complete solutions ... system for chromatin immunoprecipitation, alleviating the need for ... and controls needed for ChIP of histones or ...
(Date:1/22/2015)...   GenoSpace , a precision medicine software company that has ... use of genomic, imaging and other biomedical data in research ... Munson , CEO of Aspera, an IBM Company, to its ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to welcome ...
(Date:12/24/2014)... DALLAS and NEW YORK , ... a biopharmaceutical company advancing patient care in critical areas, announced ... of common stock, and warrants to purchase up to an ... of $4.00 per share and $.01 per warrant.  The warrants ...
(Date:12/24/2014)... Louis, Missouri (PRWEB) December 23, 2014 GMO ... biotechnology company, Syngenta, are in the process of being consolidated ... case is In Re: Syngenta AG MIR 162 Corn Litigation, ... District of Kansas. , Management of the Syngenta GMO corn ...
Breaking Biology Technology:Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
... Bulletin Board: ACCP) announced today that it will make ... Conference to be held,November 10-12, 2008 at the New ... scheduled to speak on Tuesday, November 11, 2008 at ... and discuss the Company,s,product opportunities., The presentation will ...
... ROCKVILLE, Md., Nov. 6 EntreMed, Inc.,(Nasdaq: ... the treatment of cancer and inflammatory diseases, today,reported ... September 30,2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO ), ... approximately $3,501,000,versus $3,520,000 for the comparable period a ...
... safety profile of Ranexa -, - Conference ... -, PALO ALTO, Calif., Nov. 6 ... that the U.S. Food and Drug,Administration (FDA) has ... extended-release tablets) for the treatment of,chronic angina. The ...
Cached Biology Technology:Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference 2EntreMed Reports Third Quarter 2008 Financial Results 2EntreMed Reports Third Quarter 2008 Financial Results 3EntreMed Reports Third Quarter 2008 Financial Results 4EntreMed Reports Third Quarter 2008 Financial Results 5FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 2FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 3FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 4FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 5
... 400 unique human proteins on a ... proteins, a cross section of all ... for high-quality results. Additional control proteins ... high validity and reproducibility., ,UNIchip protein ...
...
... The benchmark for analytical performance ... ease-of-use and the ultimate in ... Varian 810-MS features include: ... optics minimize,interferences, providing reliable, routine, ...
... it uses a deep-UV deuterium bulb, which provides ... a shutter (controlled via a TTL signal or ... DH-2000 Deuterium Tungsten Halogen Light Source combines the ... sources in a single optical path. The combined-spectrum ...
Biology Products: